Osaka Soda Co (4046) Q2 2027 earnings summary

Executive summary

• H1 net sales rose 14.8% YoY to ¥56,082m; operating profit rose 33.6% to ¥10,836m, both record highs for the period.

• Ordinary profit increased 29.9% to ¥11,572m and profit attributable to owners of parent rose 18.7% to ¥8,016m.

Financial highlights

• Gross profit was ¥19,619m versus ¥15,951m YoY; SG&A rose to ¥8,783m from ¥7,840m.

• Comprehensive income increased to ¥11,288m from ¥8,270m, including ¥3,272m of other comprehensive income.

• Extraordinary income was ¥132m versus ¥877m YoY; current-period profit included ¥180m of losses on retirement of non-current assets.

Outlook and guidance

• FY27 forecast unchanged: net sales ¥108,000m, operating profit ¥20,500m, ordinary profit ¥22,100m and profit attributable to owners of parent ¥14,800m.

• FY27 forecast EPS is ¥121.74; interim dividend is ¥16/share and forecast year-end dividend is ¥16/share, for ¥32/share annually, revised from the prior forecast.

• Pharmaceutical purification capacity at Amagasaki and Matsuyama is targeted to approximately double by February 2028.